Sign In
Buy TWST
$72.33
+2.18 (+3.11%)
At Close: Jun 03, 2026
SG Americas Securities LLC Acquires 59,500 Shares of Twist Bioscience Corporation $TWST
04:47am, Sunday, 05'th Apr 2026
SG Americas Securities LLC lifted its holdings in Twist Bioscience Corporation (NASDAQ: TWST) by 350.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund
Twist Bioscience Corporation (NASDAQ:TWST) Receives Average Rating of “Moderate Buy” from Analysts
04:43am, Friday, 03'rd Apr 2026
Twist Bioscience Corporation (NASDAQ: TWST - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the nine brokerages that are presently covering the company, Marketbeat.com r
Zenas BioPharma (NASDAQ:ZBIO) versus Twist Bioscience (NASDAQ:TWST) Critical Analysis
01:28am, Saturday, 28'th Mar 2026
Twist Bioscience (NASDAQ: TWST - Get Free Report) and Zenas BioPharma (NASDAQ: ZBIO - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses
Twist Bioscience Corporation (TWST) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
06:00pm, Tuesday, 10'th Mar 2026
Twist Bioscience Corporation (TWST) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Citigroup Inc. Cuts Position in Twist Bioscience Corporation $TWST
03:54am, Saturday, 07'th Mar 2026
Citigroup Inc. reduced its position in Twist Bioscience Corporation (NASDAQ: TWST) by 24.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exc
Artisan Partners Limited Partnership Grows Stake in Twist Bioscience Corporation $TWST
03:26am, Friday, 27'th Feb 2026
Artisan Partners Limited Partnership boosted its stake in Twist Bioscience Corporation (NASDAQ: TWST) by 26.7% during the third quarter, according to its most recent 13F filing with the Securities and
Twist Bioscience (NASDAQ:TWST) Shares Gap Down – What’s Next?
03:26am, Sunday, 22'nd Feb 2026
Shares of Twist Bioscience Corporation (NASDAQ: TWST - Get Free Report) gapped down prior to trading on Friday. The stock had previously closed at $52.49, but opened at $49.90. Twist Bioscience shares
Twist Bioscience Corporation (TWST) Shareholder/Analyst Call Transcript
03:54pm, Wednesday, 18'th Feb 2026
Twist Bioscience Corporation (TWST) Shareholder/Analyst Call Transcript
Cathie Wood Bets Big on Semiconductors, Adds Broadcom and AMD
09:49am, Wednesday, 18'th Feb 2026
Cathie Wood's ARK Invest ETFs made notable portfolio moves on Tuesday, according to a Tuesday filing with the SEC.Wood increased exposure to semiconductor firms
Twist Bioscience to Present at Upcoming Investor Conferences
08:00am, Wednesday, 18'th Feb 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder
Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement
07:00am, Tuesday, 17'th Feb 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it has entered into a licensing agreement wi
Biotech Beat Nvidia in 2025. Can It Do It Again?
09:51am, Wednesday, 11'th Feb 2026
In this podcast, Motley Fool analysts Karl Thiel, Tom King, and Tim Beyers discuss:
Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes
08:00am, Tuesday, 10'th Feb 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp Library Preparation Kit and Twis
Twist Bioscience: Liquid Biopsy And AI Tailwinds
02:53am, Tuesday, 10'th Feb 2026
Twist Bioscience's stock has moved high in recent months, driven by optimism related to AI-enabled drug discovery and MRD testing. Q1 growth was modest, due in large part to an air pocket in demand ca
These Analysts Increase Their Forecasts On Twist Bioscience After Q1 Results
09:27am, Tuesday, 03'rd Feb 2026
Twist Bioscience Corporation (NASDAQ: TWST) on Monday posted better-than-expected sales for the first quarter.
